Formulation of caffeine injection for I.v. administration
Nahata, M.C.; Roberts, D.L.
American Journal of Hospital Pharmacy 44(6): 1308; 1312
1987
ISSN/ISBN: 0002-9289 PMID: 3618604 Document Number: 287045
Document emailed within 1 workday
Related Documents
2003: Paracetamol for injection: new formulation. New formulation: why so widely used? Prescrire International 12(67): 178Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350
Scheidel, B.; Blume, H.; Walter, K.; von Nieciecki, A.; Babej-Dölle, R.M. 1993: Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation Arzneimittel-Forschung 43(11): 1211-1215
Jain, N.K.; Agrawal, R.K.; Singhai, A.K. 1990: Formulation of aqueous injection of carbamazepine Die Pharmazie 45(3): 221-222
Helmsing, P.J.; Huisman, R.; van der Weele, A. 1993: HPLC determination of caffeine and theophylline by direct serum injection Clinical Chemistry 39(6): 1348-1349
Gale, G.R.; Smith, A.B. 1988: Interaction of caffeine with acetaminophen in mice: schedule dependency of the antagonism by caffeine of acetaminophen hepatotoxicity and the effects of caffeine metabolites, allopurinol, and diethyl ether Research Communications in Chemical Pathology and Pharmacology 59(3): 305-320
Guo, Y.; Chen, X.; Zhao, Y.; Sun, J. 1996: Screening for the new formulation of 25% ascorbic acid injection and studies on its stability Hua Xi Yi Ke da Xue Xue Bao 27(3): 327-331
Röhrborn, G. 1972: Studies on mutagenity in mice after administration of caffeine Zeitschrift für Ernahrungswissenschaft. Journal of Nutritional Sciences. Supplementa 14: Suppl 14: 54-67
Walczak, M.; Michalkiewicz, M.; Piontek, E. 1975: Immunoreactive insulin in children following oral administration of caffeine Pediatria Polska 50(9): 1119-1123
Callahan, M.M.; Robertson, R.S.; Arnaud, M.J.; Branfman, A.R.; McComish, M.F.; Yesair, D.W. 1982: Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(4): 417-423
Bojanowicz, K.; Rybarczyk, Z.; Lewiński, A. 1979: New method of studying the secretory reactivity of the stomach after subcutaneous injection of caffeine in healthy subjects and in patients with peptic ulcer Wiadomosci Lekarskie 32(4): 221-226
Regazzi, M.B.; Rondanelli, R.; Calvi, M.; Brè, E.; Restelli, E. 1985: In vivo disposibility of caffeine and ergotamine tartrate after rectal administration Il Farmaco; Edizione Pratica 40(8): 259-265
Dodov, M.Glavas.; Goracinova, K.; Simonoska, M.; Trajkovic-Jolevska, S.; Ribarska, J.Tonic.; Mitevska, M.Dastevska. 2005: Formulation and evaluation of diazepam hydrogel for rectal administration Acta Pharmaceutica 55(3): 251-261
Kim, S.Tae.; Jang, D-Jin.; Kim, J.Hyo.; Park, J.Yeon.; Lim, J.Soo.; Lee, S.Yeon.; Lee, K-Mi.; Lim, S-Jeong.; Kim, C-Kook. 2009: Topical administration of cyclosporin A in a solid lipid nanoparticle formulation Die Pharmazie 64(8): 510-514
Newman, S.P.; Steed, K.P.; Hardy, J.G.; Wilding, I.R.; Hooper, G.; Sparrow, R.A. 1994: The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques Journal of Pharmacy and Pharmacology 46(8): 657-660
Johnston, A. 1996: Estrogens--pharmacokinetics and pharmacodynamics with special reference to vaginal administration and the new estradiol formulation--Estring Acta Obstetricia et Gynecologica Scandinavica. Supplement 163: 16-25
Budai, P.; Fejes, S.; Várnagy, L.; Szabó, R.; Keserü, M. 2002: Embryonic toxicity of a dimethoate containing insecticide formulation and Cu-sulphate in chicken after individual or combined administration Mededelingen 67(2): 99-103
Friedman, D.; Pathak, Y.V.; Benita, S. 1989: Micronized emulsion for controlled release of physostigmine after oral administration. Part I. Formulation design Drug Design and Delivery 4(2): 135-142
Fejes, S.; Budai, P.; Várnagy, L.; Molnár, T.; Szabó, R.; Fáncsi, T. 2002: Toxicity of a mancozeb containing fungicide formulation and CU-sulphate to chicken embryos after administration as single compounds or in combination Mededelingen 67(2): 105-109
Assinder, D.F.; Chasseaud, L.F.; Hunter, J.O.; Jung, R.J.; Taylor, T. 1977: Plasma concentrations of isosorbide dinitrate after oral administration of a sustained-release formulation to human subjects Arzneimittel-Forschung 27(1): 156-158